For the quarter ending 2026-03-31, UPB has $318,054K in assets. $14,059K in debts. $96,724K in cash and cash equivalents.
| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 96,724 | 101,578 | 72,164 | 45,458 |
| Short-term investments | 197,855 | 239,931 | 300,263 | 348,123 |
| Accounts receivable | 1,034 | 668 | 683 | 937 |
| Prepaid expenses and other current assets | 20,666 | 9,620 | 15,907 | 23,754 |
| Total current assets | 316,279 | 351,797 | 389,017 | 418,272 |
| Property and equipment, gross | 903 | 903 | 903 | - |
| Less accumulated depreciation and amortization | 393 | 344 | 287 | - |
| Property and equipment, net | 510 | 559 | 616 | 544 |
| Operating lease right-of-use assets | 1,071 | 1,222 | 1,368 | 1,511 |
| Restricted cash | 194 | 194 | 194 | 194 |
| Total assets | 318,054 | 353,772 | 391,195 | 420,521 |
| Accounts payable | 1,710 | 2,726 | 3,952 | 2,551 |
| Accrued expenses and other current liabilities | 11,235 | 10,006 | 7,240 | 7,666 |
| Operating lease liabilities, current portion | 724 | 720 | 716 | 712 |
| Total current liabilities | 13,669 | 13,452 | 11,908 | 10,929 |
| Operating lease liabilities, net of current portion | 390 | 549 | 703 | 849 |
| Total liabilities | 14,059 | 14,001 | 12,611 | 11,778 |
| Common stock, 0.001 par value 500,000,000 shares authorized at march 31, 2026 and december 31, 2025 54,419,986 and 54,237,750 shares issued and outstanding at march 31, 2026 and december 31, 2025, respectively | 54 | 54 | 56 | 54 |
| Additional paid-in capital | 678,655 | 673,410 | 669,799 | 666,447 |
| Accumulated other comprehensive income | 100 | 530 | 493 | 258 |
| Accumulated deficit | -374,814 | -334,223 | -291,764 | -258,016 |
| Total stockholders' deficit | 303,995 | 339,771 | 378,584 | 408,743 |
| Total liabilities, redeemable convertible preferred stock and stockholders' deficit | 318,054 | 353,772 | 391,195 | 420,521 |
Upstream Bio, Inc. (UPB)
Upstream Bio, Inc. (UPB)